These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 50452)

  • 21. Lupus-like syndromes induced by drugs.
    Harpey JP
    Ann Allergy; 1974 Nov; 33(5):256-61. PubMed ID: 4138815
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical grand rounds--from the Medical College of Virginia. Drug-induced lupus erythematosus.
    Va Med Mon (1918); 1974 Apr; 101(4):299-301 passim. PubMed ID: 4545011
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute lupus erythematosus induced by procainamide].
    Manigand G; Foulon D; Perrigot M; Deparis M
    Sem Hop; 1973 Nov; 49(48):3207-10. PubMed ID: 4364913
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptive therapy and systemic lupus erythematosus.
    Travers RL; Hughes GR
    J Rheumatol; 1978; 5(4):448-51. PubMed ID: 310887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal findings in the blood in SLE].
    Ofuji T; Miyawaki S; Sato H; Morita M; Nishishita S
    Nihon Rinsho; 1968 Dec; 26(12):3449-58. PubMed ID: 4181084
    [No Abstract]   [Full Text] [Related]  

  • 28. The value of anti-DNA antibody titers in the early diagnosis, treatment and follow-up of systemic lupus erythematosus.
    Pick AI; Levo Y; Weiss C
    Isr J Med Sci; 1974 Jul; 10(7):725-30. PubMed ID: 4137310
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
    Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
    Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Seronegative leukocytoclastic vasculitis preceding the onset of disseminated systemic lupus erythematosus].
    Chevalier X; Belmatoug N; Kahn MF
    Rev Rhum Mal Osteoartic; 1990 Nov; 57(11):779-83. PubMed ID: 2291068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies.
    Ullman S; Wiik A; Kobayasi T; Halberg P
    Acta Derm Venereol; 1974; 54(5):387-90. PubMed ID: 4138086
    [No Abstract]   [Full Text] [Related]  

  • 32. [Systemic lupus erythematosus--clinical aspects and laboratory findings].
    Fellmann B; Grob PJ
    Schweiz Med Wochenschr; 1979 Sep; 109(34):1237-50. PubMed ID: 386495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic lupus erythematosus. Some contemporary laboratory aspects.
    Deegan MJ
    Arch Pathol Lab Med; 1980 Aug; 104(8):399-404. PubMed ID: 6967303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of anti-DNA idiotype markers with clinical and serological manifestations in patients with systemic lupus erythematosus.
    Rauch J; Hazeltine M; Tannenbaum H; Danoff D; Isenberg DA; Wild J; Sampalis J; Esdaile JM
    J Rheumatol; 1990 Feb; 17(2):178-85. PubMed ID: 2108245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SLE: idiopathic or drug-induced?
    Condemi JJ
    Geriatrics; 1980 Mar; 35(3):81-8. PubMed ID: 6965485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procainamide-induced systemic lupus erythematosus.
    Atkins CJ; Hamilton EB
    Proc R Soc Med; 1969 Feb; 62(2):197-8. PubMed ID: 4180268
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of severity and native anti-DNA antibody levels in systemic lupus erythematosus. Serodiscordant lupus].
    Manent-Ducreuzet C; Margulis J; Kahn MF
    Rev Rhum Mal Osteoartic; 1981 Nov; 48(11):705-12. PubMed ID: 6975965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seronegative systemic lupus erythematosus.
    Bohan A
    J Rheumatol; 1979; 6(5):534-40. PubMed ID: 93147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.